Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland

Kaczmarek, Krzysztof; Kempa, Maciej; Grabowski, Marcin; Tajstra, Mateusz; Sokal, Adam; Cygankiewicz, Iwona; Zwoliński, Radosław; Michalak, Marcin; Kowara, Michał; Budrejko, Szymon; Klinke, Anna; Wranicz, Jerzy Krzysztof; Raczak, Grzegorz; Opolski, Grzegorz; Gąsior, Mariusz; Kowalski, Oskar; Ptaszyński, Paweł

doi:10.5114/aoms.2019.83817

Cited by 4 publications

(3 citation statements)

References 36 publications

(64 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the first implantation of an S-ICD in Poland in October 2014, the procedure has been successfully introduced to clinical practice. No early or late complications have been observed so far [34][35][36]. The experience of our department is similar.…”

Section: Discussionsupporting

confidence: 69%

Application of Novel Technologies in Cardiac Electrotherapy to Prevent Complications

et al. 2023

Self Cite

View full text Add to dashboard Cite

(1) Background: Cardiac electrotherapy is developing quickly, which implies that it will face a higher number of complications, with cardiac device-related infective endocarditis (CDRIE) being the most frequent, but not the only one. (2) Methods: This is a retrospective case study followed by a literature review, which presents a patient with a rare but dangerous complication of electrotherapy, which could have been prevented if modern technology had been used. (3) Results: A 34-year-old female was admitted with suspicion of CDRIE based on an unclear echocardiographic presentation. However, with no signs of infection, that diagnosis was not confirmed, though an endocardial implantable cardioverter-defibrillator (ICD) lead was found folded into the pulmonary trunk. The final treatment included transvenous lead extraction (TLE) and subcutaneous ICD (S-ICD) implantation. (4) Conclusions: With the increasing number of implantations of cardiac electronic devices and their consequences, a high index of suspicion among clinicians is required. The entity of the clinical picture must be thoroughly considered, and various diagnostic tools should be applied. Lead dislocation into the pulmonary trunk is an extremely rare complication. Our findings align with the available literature data, where asymptomatic cases are usually effectively treated with TLE. Modern technologies, such as S-ICD, can effectively prevent lead-related problems and are indicated in young patients necessitating long-term ICD therapy.

show abstract

Section: Discussionsupporting

confidence: 69%

Application of Novel Technologies in Cardiac Electrotherapy to Prevent Complications

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…We compared data collected in two registries in different time intervals: Registry A -September 2014 to December 2015, and Registry B -May 2020 to May 2021. Registry A was a multicenter query reporting data of 18 patients from 5 centers that pioneered S-ICD implantations in Poland [6]. Registry B is a nationwide initiative held by the Heart Rhythm Section of the Polish Cardiac Society [7], and 16 centers performing S-ICD implantations report data of subsequent patients undergoing implantation or exchange of the device.…”

Section: Methodsmentioning

confidence: 99%

Evolution of implantation technique and indications for a subcutaneous cardioverter-defibrillator: over 7 years of experience in Poland

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…The most important advantage of the transvenous ICD (TV-ICD) is that it is a relatively safe, minimally invasive surgery, with a low complication rate. Nonetheless, even rarely observed lead-dependent problems may be life threatening, i.e., cardiac tamponade or infective endocarditis [ 3 , 4 , 5 , 6 ]. A totally subcutaneous ICD (S-ICD) was introduced as an aid for prevention of SCD.…”

Section: Introductionmentioning

confidence: 99%

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience

Wieniawski

Buczyński

Grabowski

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

Background: The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the transvenous ICD, to prevent lead-related complications associated with the latter. The absence of intravascular or intracardiac components offers potential advantages to pediatric patients. Aims: The aim of the study is to present an overview of our experience with S-ICDs in the pediatric center that, currently, has performed the largest number of implantations in children in Poland. Methods: Retrospective analysis of data from medical history, qualification, implantation procedure, and S-ICD post-implantation observations in 11 pediatric patients were performed. Results: S-ICDs were implanted in 11 patients, 8 boys and 3 girls, aged 12–17 years. The S-ICD was implanted for primary prevention in seven patients: four with hypertrophic cardiomyopathy (HCM), two with dilated cardiomyopathy (DCM), and one with arrhythmogenic right ventricular cardiomyopathy (ARVC). It was implanted for secondary prevention in four patients: two with sudden cardiac arrest (SCA) in the course of idiopathic ventricular fibrillation (IVF), one with long QT syndrome (LQTS) after probable SCA, and one with Brugada syndrome after SCA. In all patients, the device was implanted intramuscularly. One patient did not have a defibrillation test performed due to the presence of an intracardiac thrombus. In one patient, during screening, it was decided to implant an electrode on the right side of the sternum. There were no early or late complications with any of the procedures. So far, no inadequate discharges have been observed. Conclusions: Our results prove the efficacy of the S-ICD treatment option along with technically simple surgery, which supports its further and more widespread application in children.

show abstract

Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland

Cited by 4 publications

References 36 publications

Application of Novel Technologies in Cardiac Electrotherapy to Prevent Complications

Application of Novel Technologies in Cardiac Electrotherapy to Prevent Complications

Evolution of implantation technique and indications for a subcutaneous cardioverter-defibrillator: over 7 years of experience in Poland

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience

Contact Info

Product

Resources

About